Defining a Target Population to Effectively Test a Neuroprotective Drug. Olive-Gadea M, Requena M, Campos D, Garcia-Tornel A, et al. Stroke 2021 Jan 11:STROKEAHA120032025. doi: 10.1161/STROKEAHA.120.032025.

Read + Share

Amedeo Smart

Independent Medical Education

Olive-Gadea M, Requena M, Campos D, Garcia-Tornel A, et al. Defining a Target Population to Effectively Test a Neuroprotective Drug. Stroke 2021 Jan 11:STROKEAHA120032025. doi: 10.1161/STROKEAHA.120.032025.
PMID: 33423513